BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 28360085)

  • 1. Silencing of translation initiation factor eIF3b promotes apoptosis in osteosarcoma cells.
    Choi YJ; Lee YS; Lee HW; Shim DM; Seo SW
    Bone Joint Res; 2017 Mar; 6(3):186-193. PubMed ID: 28360085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eukaryotic translation initiation factor 3B downregulation inhibits cell proliferation and promotes cell apoptosis through negatively regulating tumor necrosis factor receptor superfamily member 21 in gastric cancer.
    Xiong H; Hu M; Huang H; Gong J; Wu J; Zhang H
    Transl Cancer Res; 2019 Oct; 8(6):2242-2251. PubMed ID: 35116977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of eukaryotic translation initiation factors 3B (EIF3B) inhibits proliferation and promotes apoptosis in glioblastoma cells.
    Liang H; Ding X; Zhou C; Zhang Y; Xu M; Zhang C; Xu L
    Neurol Sci; 2012 Oct; 33(5):1057-62. PubMed ID: 22234522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eukaryotic translation initiation factor 3B accelerates the progression of esophageal squamous cell carcinoma by activating β-catenin signaling pathway.
    Xu F; Xu CZ; Gu J; Liu X; Liu R; Huang E; Yuan Y; Zhao G; Jiang J; Xu C; Chu Y; Lu C; Ge D
    Oncotarget; 2016 Jul; 7(28):43401-43411. PubMed ID: 27270324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eukaryotic translation initiation factor 3 subunit b is a novel oncogenic factor in prostate cancer.
    Xiang P; Sun Y; Fang Z; Yan K; Fan Y
    Mamm Genome; 2020 Aug; 31(7-8):197-204. PubMed ID: 32556998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EIF3B promotes cancer progression in pancreatic cancer.
    Zhu H; Shan Y; Ge K; Lu J; Kong W; Jia C
    Scand J Gastroenterol; 2021 Mar; 56(3):281-288. PubMed ID: 33459066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of eukaryotic translation initiation factor 3 subunit B inhibits cell proliferation and migration and promotes apoptosis by downregulating WNT signaling pathway in acute myeloid leukemia.
    Feng Y; Wu L
    Int J Clin Exp Pathol; 2020; 13(1):99-106. PubMed ID: 32055278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of eukaryotic initiation factor 3B suppresses proliferation and promotes apoptosis of chronic myeloid leukemia cells.
    Huang L; He K; Wang J; Yan J; Jiang Y; Wei Z; Zhang J; Li G; Sheng L
    Adv Clin Exp Med; 2019 Dec; 28(12):1639-1645. PubMed ID: 31778600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. eIF3b regulates the cell proliferation and apoptosis processes in chronic myelogenous leukemia cell lines via regulating the expression of C3G.
    Huang L; Wei Z; Chang X; Zheng X; Yan J; Huang J; Zhang J; Sheng L
    Biotechnol Lett; 2020 Jul; 42(7):1275-1286. PubMed ID: 32236758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eukaryotic translation initiation factor 3 subunit B could serve as a potential prognostic predictor for breast cancer.
    Song S; Liu J; Zhang M; Gao X; Sun W; Liu P; Wang Y; Li J
    Bioengineered; 2022 Feb; 13(2):2762-2776. PubMed ID: 35040374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA interference-mediated silencing of eukaryotic translation initiation factor 3, subunit B (EIF3B) gene expression inhibits proliferation of colon cancer cells.
    Wang Z; Chen J; Sun J; Cui Z; Wu H
    World J Surg Oncol; 2012 Jun; 10():119. PubMed ID: 22734884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of EIF3B gene downregulation on apoptosis and proliferation of human ovarian cancer SKOV3 and HO-8910 cells.
    Wang L; Ouyang L
    Biomed Pharmacother; 2019 Jan; 109():831-837. PubMed ID: 30551537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eukaryotic initiation factor 3b regulates the development and progression of breast cancer.
    Li Y; Zhao J; Yuan Z; Yuan D; Fang M; Xie M; Xia M
    Am J Cancer Res; 2023; 13(5):2188-2200. PubMed ID: 37293180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TEX9 and eIF3b functionally synergize to promote the progression of esophageal squamous cell carcinoma.
    Xu F; Zhang S; Liu Z; Gu J; Li Y; Wang L; Mao W; Zhu Q; Shou H; Ge D; Lu C
    BMC Cancer; 2019 Sep; 19(1):875. PubMed ID: 31481019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eukaryotic Translation Initiation Factor 3 Subunit B Is a Promoter in the Development and Progression of Pancreatic Cancer.
    Ren H; Mai G; Liu Y; Xiang R; Yang C; Su W
    Front Oncol; 2021; 11():644156. PubMed ID: 33996561
    [No Abstract]   [Full Text] [Related]  

  • 16. Translation initiation factor eIF3b expression in human cancer and its role in tumor growth and lung colonization.
    Wang H; Ru Y; Sanchez-Carbayo M; Wang X; Kieft JS; Theodorescu D
    Clin Cancer Res; 2013 Jun; 19(11):2850-60. PubMed ID: 23575475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eukaryotic translation initiation factor 3 subunit B promotes head and neck cancer via CEBPB translation.
    Xu C; Shen Y; Shi Y; Zhang M; Zhou L
    Cancer Cell Int; 2022 Apr; 22(1):161. PubMed ID: 35459206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EIF3B correlates with advanced disease stages and poor prognosis, and it promotes proliferation and inhibits apoptosis in non-small cell lung cancer.
    Tian Y; Zhao K; Yuan L; Li J; Feng S; Feng Y; Fang Z; Li H; Deng R
    Cancer Biomark; 2018; 23(2):291-300. PubMed ID: 30198870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eukaryotic Translation Initiation Factor 3b is both a Promising Prognostic Biomarker and a Potential Therapeutic Target for Patients with Clear Cell Renal Cell Carcinoma.
    Zang Y; Zhang X; Yan L; Gu G; Li D; Zhang Y; Fang L; Fu S; Ren J; Xu Z
    J Cancer; 2017; 8(15):3049-3061. PubMed ID: 28928896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eukaryotic initiation factor 3B downregulation suppresses cell proliferation, migration and invasion while it induces cell apoptosis by blocking the β-catenin pathway in endometrial cancer.
    Min J; Chen H
    Int J Clin Exp Pathol; 2019; 12(9):3595-3603. PubMed ID: 31934209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.